Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Colistin resistance during selective digestive tract decontamination is uncommon.

Zandstra DF, Rommes JH, de la Cal MA, Silvestri L, Taylor N, van Saene HK.

Antimicrob Agents Chemother. 2014;58(1):626. doi: 10.1128/AAC.01284-13. No abstract available.

2.

Reply to "colistin resistance during selective digestive tract decontamination is uncommon".

Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Vandenbroucke-Grauls CM.

Antimicrob Agents Chemother. 2014;58(1):627. doi: 10.1128/AAC.02021-13. No abstract available.

3.

Selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene.

Krueger WA, Heininger A, Grabein B, Unertl K, Sánchez-García M.

Antimicrob Agents Chemother. 2014 Jun;58(6):3574-5. doi: 10.1128/AAC.02313-13. No abstract available.

4.

Reply to "selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene".

Halaby T, Al Naiemi N, Vandenbroucke-Grauls CM.

Antimicrob Agents Chemother. 2014 Jun;58(6):3576-8. doi: 10.1128/AAC.02814-13. No abstract available.

5.

Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit.

Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Vandenbroucke-Grauls CM.

Antimicrob Agents Chemother. 2013 Jul;57(7):3224-9. doi: 10.1128/AAC.02634-12. Epub 2013 Apr 29.

6.

Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract.

Brink AJ, Coetzee J, Corcoran C, Clay CG, Hari-Makkan D, Jacobson RK, Richards GA, Feldman C, Nutt L, van Greune J, Deetlefs JD, Swart K, Devenish L, Poirel L, Nordmann P.

J Clin Microbiol. 2013 Jan;51(1):369-72. doi: 10.1128/JCM.02234-12. Epub 2012 Nov 14.

7.

Colistin and tobramycin resistance during long- term use of selective decontamination strategies in the intensive care unit: a post hoc analysis.

Wittekamp BH, Oostdijk EA, de Smet AM, Bonten MJ.

Crit Care. 2015 Mar 25;19:113. doi: 10.1186/s13054-015-0838-4.

8.

Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.

Lübbert C, Faucheux S, Becker-Rux D, Laudi S, Dürrbeck A, Busch T, Gastmeier P, Eckmanns T, Rodloff AC, Kaisers UX.

Int J Antimicrob Agents. 2013 Dec;42(6):565-70. doi: 10.1016/j.ijantimicag.2013.08.008. Epub 2013 Sep 19.

PMID:
24100228
10.

[Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].

Hostacká A, Ciznár I.

Epidemiol Mikrobiol Imunol. 2008 Aug;57(3):101-5. Slovak.

PMID:
18767377
11.

Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae.

Meletis G, Tzampaz E, Sianou E, Tzavaras I, Sofianou D.

J Antimicrob Chemother. 2011 Apr;66(4):946-7. doi: 10.1093/jac/dkr007. Epub 2011 Jan 25. No abstract available.

PMID:
21393203
12.

Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.

Suh JY, Son JS, Chung DR, Peck KR, Ko KS, Song JH.

Antimicrob Agents Chemother. 2010 Jan;54(1):560-2. doi: 10.1128/AAC.00762-09. Epub 2009 Sep 14.

13.

Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan.

Cheng YH, Lin TL, Pan YJ, Wang YP, Lin YT, Wang JT.

Antimicrob Agents Chemother. 2015 May;59(5):2909-13. doi: 10.1128/AAC.04763-14. Epub 2015 Feb 17.

14.

Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.

Valenza G, Radike K, Schoen C, Horn S, Oesterlein A, Frosch M, Abele-Horn M, Hebestreit H.

Scand J Infect Dis. 2010 Dec;42(11-12):885-9. doi: 10.3109/00365548.2010.509333. Epub 2010 Aug 25.

PMID:
20735333
15.

[Selective decontamination of the digestive tract: repercussions on microbiology laboratory workload and costs, and antibiotic resistance trends].

García-San Vicente B, Canut A, Labora A, Otazua M, Corral E.

Enferm Infecc Microbiol Clin. 2010 Feb;28(2):75-81. doi: 10.1016/j.eimc.2009.03.005. Epub 2009 Jul 25. Spanish.

PMID:
19632746
16.

First report of colistin-resistant KPC-2 producing ST258-Klebsiella pneumoniae in Spain.

Valentín-Martín A, Valverde-De Francisco A, Bosque-Vall M, Cantón-Moreno R.

Enferm Infecc Microbiol Clin. 2013 Aug-Sep;31(7):489-91. doi: 10.1016/j.eimc.2012.12.002. Epub 2013 Feb 22. No abstract available.

PMID:
23462465
17.

Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?

Souli M, Rekatsina PD, Chryssouli Z, Galani I, Giamarellou H, Kanellakopoulou K.

Antimicrob Agents Chemother. 2009 May;53(5):2133-5. doi: 10.1128/AAC.01271-08. Epub 2009 Mar 2.

18.

Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study.

de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT, Kuijper EJ, Leverstein-van Hall MA, Jansz AR, de Jongh BM, van Asselt GJ, Frenay IH, Thijsen SF, Conijn SN, Kaan JA, Arends JP, Sturm PD, Bootsma MC, Bonten MJ.

Lancet Infect Dis. 2011 May;11(5):372-80. doi: 10.1016/S1473-3099(11)70035-4. Epub 2011 Mar 21.

PMID:
21420908
19.

Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.

Bogdanovich T, Adams-Haduch JM, Tian GB, Nguyen MH, Kwak EJ, Muto CA, Doi Y.

Clin Infect Dis. 2011 Aug;53(4):373-6. doi: 10.1093/cid/cir401.

20.

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Endimiani A, Patel G, Hujer KM, Swaminathan M, Perez F, Rice LB, Jacobs MR, Bonomo RA.

Antimicrob Agents Chemother. 2010 Jan;54(1):526-9. doi: 10.1128/AAC.01235-09. Epub 2009 Nov 9.

Supplemental Content

Support Center